High Health-Care Utilization (HCU) and Costs Associated with Diabetes Mellitus (DM) and Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) in Medicare Patients

被引：0
|
作者：
Gordon, Stuart
Fraysse, Jeremy
Li, Suying
Ozbay, A. Burak
Wong, Robert
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-1253-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1253-P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus
    Paola Portillo-Sanchez
    Kenneth Cusi
    Clinical Diabetes and Endocrinology, 2 (1):
  • [42] Rising and Higher Healthcare Resource Utilization (HCRU) and Costs of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH) Patients with Advanced Liver Disease of Increasing Severity - Results of a US Real-World Analysis
    Wong, Robert J.
    Kachru, Nandita
    Meyer, Nicole
    Gordon, Stuart C.
    HEPATOLOGY, 2018, 68 : 1283A - 1284A
  • [43] PATHOGENETIC ANALYSIS OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) WITH MULTI-CELL-LINEAGE HUMAN LIVER ORGANOIDS
    Zhang, Wenjun
    Park, Yujin
    Thadasina, Deepthi
    Thi Minh Uyen Le
    Li, Ping
    Ekser, Burcin
    HEPATOLOGY, 2023, 78 : S1121 - S1122
  • [44] Prevalence and predictors of de novo nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) after orthotopic liver transplantation (OLT)
    Seo, Suk
    Maganti, Kalyani
    Khehra, Manjit
    Ramsamooj, Rajendra
    Tsodikov, Alexander
    Torok, Natalie
    GASTROENTEROLOGY, 2006, 130 (04) : A789 - A789
  • [45] MRE-based NASH score for diagnosis of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
    Young-Sun Lee
    Ji Eun Lee
    Hyon-Seung Yi
    Young Kul Jung
    Dae Won Jun
    Ji Hoon Kim
    Yeon Seok Seo
    Hyung Joon Yim
    Baek-hui Kim
    Jeong Woo Kim
    Chang Hee Lee
    Jong Eun Yeon
    Juneyoung Lee
    Soon Ho Um
    Kwan Soo Byun
    Hepatology International, 2022, 16 : 316 - 324
  • [46] MRE-based NASH score for diagnosis of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
    Lee, Young-Sun
    Lee, Ji Eun
    Yi, Hyon-Seung
    Jung, Young Kul
    Jun, Dae Won
    Kim, Ji Hoon
    Seo, Yeon Seok
    Yim, Hyung Joon
    Kim, Baek-hui
    Kim, Jeong Woo
    Lee, Chang Hee
    Yeon, Jong Eun
    Lee, Juneyoung
    Um, Soon Ho
    Byun, Kwan Soo
    HEPATOLOGY INTERNATIONAL, 2022, 16 (02) : 316 - 324
  • [47] Therapeutic Effects of microRNAs on Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): A Systematic Review and Meta-Analysis
    Zhu, Yuezhi
    Tan, Jen Kit
    Wong, Sok Kuan
    Goon, Jo Aan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
  • [48] Liver Fibrosis Is Common in Patients with Type 2 Diabetes Mellitus (T2DM) and Nonalcoholic Fatty Liver Disease (NAFLD)
    Lomonaco, Romina
    Fanous, Nada
    Kalavalapalli, Srilaxmi
    Tejera, Lazaro J.
    McCauley, Allison
    Godinez, Eddison
    Mansour, Lydia
    Shrestha, Sulav
    Marte, Jonathan S.
    Fakhry, Jonathan
    Wang, Hannah
    Barb, Diana
    Bril, Fernando
    Cusi, Kenneth
    DIABETES, 2020, 69
  • [49] Cardiac Dysfunction in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus (T2DM)
    Zemlianitsyna, Olga
    Dunayeva, Inna
    Kravchun, Nonna
    Sinaiko, Vadym
    Lavrynenko, Olga
    DeFronzo, Ralph
    AMERICAN HEART JOURNAL, 2020, 229 : 158 - 159
  • [50] Role of plasma FGF21 as a biomarker for nonalcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH)
    Bril, Fernando
    Lomonaco, Romina
    Orsak, Beverly
    Chang, Zhi
    Ortiz-Lopez, Carolina
    Hecht, Joan
    Tio, Fermin
    Cusi, Kenneth
    HEPATOLOGY, 2013, 58 : 487A - 487A
12345